Reimbursement Of Health Care Costs. Insurance For 1. 2003.

Original Language Title: úhrady zdravotní péče hrazené ze zdrav. pojištění pro 1. pol. 2003

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
532/2002 Sb.



The DECREE



of 10 June 1999. December 2002,



laying down the amount of reimbursement of health care paid for by the public

health insurance including the regulatory limit for 1. half-year 2003



The Ministry of health shall determine in accordance with section 17 paragraph. 11 (a). (b)) of the Act

No. 48/1997 Coll., on public health insurance and amending and supplementing

some related laws, as amended by Act No. 459/2000 Coll. (hereinafter the

"the Act"):



§ 1



This Decree lays down, in cases when it is not the result of the conciliation

the management agreement provided for in § 17 paragraph. 8 of the Act,



and the amount of the reimbursement) of health care paid for by public health insurance

including the regulatory restrictions for health care in health care

hospital care, including specialised therapeutic institutes, hospitals

for long-term patients and medical facilities treating the returning

day no. 00005 according to the Decree, which publishes a list of medical procedures

with point values in "^ 1") (hereinafter referred to as "the list of performance"),



(b) the amount of the reimbursement) of health care paid for by public health insurance

including the regulatory restrictions for health care provided in the context of the

medical emergency services, transport of the wounded, sick and expectant mothers, and

medical first aid service,



(c) the amount of the reimbursement) when providing emergency care in non-

medical facilities.



§ 2



(1) the Medical care provided in the medical facilities of the constitutional

care, with the exception of health care in specialised therapeutic institutes,

Sanatorium for long-term patients and in medical devices

returning the length of the day no. 00005 in accordance with the list of performances (hereinafter referred to as

"inpatient facilities"), shall be paid in accordance with the contractual arrangement between the health

the insurance company and patient facilities



and) flat-rate, or



(b)), or list of performances



(c) on a proposal from the socket of the device) in an agreed manner combined payments

with payment for the diagnosis.



(2) the price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 1. half of the

2003. ^ 2)



(3) the amount of remuneration referred to in paragraph 1 (b). (c)) shall negotiate in the contract between the

health insurance and the amount of fasility, payment

the provision of acute care will be provided with payment for the diagnosis and

other health care will be covered by a flat rate.



(4) any other method of payment than provided for in paragraph 1, it is possible, if

for this method of payment, the Contracting Parties agree, and this method is not in

contrary to the laws and regulations governing public health insurance.



(5) If an inpatient facility and health insurance company will agree to supplement

contract, or out a new contract, containing new health performances

provided by the device, or will agree a new structure

provided health care, health insurance, these really

the total amount of payments for 1. half of 2003 will include, if this method is not

in conflict with the law governing public health insurance.



(6) the procedure for the calculation of flat-rate, amount and conditions of payment according to the

paragraph 1 (b). and (b))) is determined in annex 1 to this notice.



(7) if the payment of the flat-rate referred to in paragraph 1 (b). and)

health insurance provides beyond the flat rate and without the application of the

other regulatory restrictions, if these are not referred to directly in the text

letters and) up in), at 1. half of 2003, particularly the payment of



and for kardiovertry and under), cardiac pacemakers, including electrodes, supplied

in the 1. half of 2003 (in the case of reimplantací feats no 55217 and 55219

referred to in the list of performance)



(b)) for the neuromodulační enhancers, supplied in 1. half-year 2003

the treatment of epilepsy and Parkinson's disease,



(c)) for neuromodulační promoters and intrathekální pumps, provided by

the treatment of chronic pain, peripheral nerve stimulation

(PNS), stimulation of the spinal cord or the rear roots (SCS), a deep brain

and korová stimulation, and promoters of the front horns spinal (SARS) for the

transversálních lesions of the dorsal root is provided in 1. half of 2003 in the bed

the establishments listed in the annex No. 3 to this notice; inpatient facilities

referred to in annex 3 to this Ordinance may apply to the sum of the

health insurance companies in the Czech Republic up to 30 programmable

prostheses,



(d)) for the treatment of in vitro fertilization, provided in the 1. half-year 2003

b devices implementing the standard treatment of sterility method

her insemination,



(e)) for the health centre performance no 18051, 18052, 18510, 18513,

18521, 18522, 18530, 18550, 18560, 18570, and 18590 18580 list

the performance, given in 1. half of 2003, while the price point for the payment

These procedures set out for the 1. half of 2001 remains in force for 1.

half-year 2003; ^ 3) for health performance no 18521, 18522, 18530, 18550,

18560, 18570, 18580 and 18590, referred to in the Decree, provides for overhead

cost of 4 points per minute,



(f)) for a particularly charged medicinal products for the treatment of hemophilia, as referred to in

Annex No 4 to this Decree, granted in the 1. half of 2003 in the bed

devices,



(g)) of a particularly charged medicinal products for the treatment of HIV/AIDS, and it

antiretroviral medicinal products and medicinal products for comprehensive treatment

opportunistic infections, provided in the 1. half of 2003 in the bed

the establishments listed in Appendix 5 to this Decree; antiretroviral

medicinal products and medicinal products for comprehensive treatment of opportunistic

infections are listed in annex 6 to this Ordinance,



(h)), the medicinal product particularly charged Cerezyme, to treat disease

Morbus Gaucher, provided in 1. half of 2003 only the clinic of child and

adolescent medicine General faculty hospital, Prague



and care days) in reanimation and intensive care no 00051 00052,,

00053, 00055, 00057, 00058, 00061, 00065, 00068 according to the performance,

provided in the 1. half of 2003 when treating extensive burns, in

inpatient facilities referred to in annex 7 to this Decree, and

the price point for the payment of such performances fixed for 1. half-year 2001

shall remain in force for 1. half of 2003, "^ 4)



(j)) of a particularly charged given in medicinal products 1. half-year 2003

in the treatment of cystic fibrosis in the bed of the establishments listed in the annex

No 8 to this Ordinance; the list of medicinal products is charged separately

contained in annex 9 to this Decree,



separately charged to) for medicinal products granted in 1. half-year 2003

oncologically ill children treated at Pediatric Oncology

inpatient facilities referred to in annex 10 to this Decree; a list of the

separately charged to the medicinal products listed in annex 11 to this

the Decree,



(l)) a particularly charged balloon catheters and Stents is provided in 1.

half of 2003 in connection with the implementation of direct percutaneous

transluminal angioplasty (PTCA) for acute myocardial infarction on

performance no 89435, 89437 and 17117, referred to in the list of performance in bed

the establishments listed in the annex to this Decree, 12



m) for a particularly charged blockers of plate glykoproteinových

receptor IIb/IIIa (ATC group B01AC13 and B01AC16) listed in the annex

No. 18 to this Decree, granted in the 1. half of 2003 in the treatment of acute

myocardial infarction in the bed of the establishments listed in the annex, no. 12 k

This Decree,



n) particularly charged balloon catheters, stents, stent-grafty,

embolizující spirálky, sticky mixture, mikrokatetry and cerebrovascular

protective equipment is provided in 1. half-year 2003, when Endovascular

treat (no performances, 89331 89423 89323 and included in the list of performance)

tepenných aneurysms and dissection, stenosis of cerebral arteries, brain

arteriovenous malformations, short circuits and devices referred to in

in annex 13 to this Decree,



about) a particularly charged material (24684 codes and 71032) provided in 1.

half of 2003 when the hernia operations by using the method of PHS (performances no 51517 and

51519 listed procedures),



p) a particularly charged material (67162 code) provided in 1. half of the

2003 in the surgical treatment of stress urinary incontinence in women (no performance.

76601 referred to in the list of performance) in in-patient establishments as referred to in

Annex 14 to this Decree,



q) posted a particularly medicinal products (codes, 75379 90996, 93706 and

93707) provided in the 1. half of 2003 in the treatment of rabies in bed

devices,



r) a particularly charged with medicinal products containing an active substance

erythropoietin listed in annex No. 15 of this notice for the treatment

multiple myeloma and chronic lymphocytic leukemia is provided in 1.

half of 2003 in the facilities referred to in annex 16 to this

the Decree,



separately charged with) for medicinal products containing an active substance

erythropoietin listed in annex No. 15 of this notice for the treatment

germinal tumors in stage II-IV ovarian carcinomas I-IIA

stages, lung cancer, breast cancer in I and II stage, cancer of the cervix

in stage Ib, IIa, IIb, cancer in the orofacial area, malignant

tumors of the placenta is provided in 1. half of 2003 in the inpatient facilities
referred to in annex 17 to this Decree,



t) a particularly charged material-splint, provided in 1. half-year 2003

in the performance of torakoplastika (no performance 57225 listed procedures),

conducted the clinic of Pediatric Surgery, University Hospital Motol, Prague 5 and

University Hospital Brno-Clinic of children's surgery, orthopedics and

traumatology. These devices can sum on health

insurance companies in the Czech Republic up to 15 individual plates in a solution

pectus excavatum,



the cochlear implant) systems, is provided in 1. half-year 2003

a sudden two-sided deafness in adults, always only when well

developed speech; in children ohluchlých postlinguálně no less than half a

year and for the deaf or ohluchlých kongenitálně prelinguálně,

provided by no later than 6 years of age, in the inpatient facilities Faculty

Hospital Motol, Prague 5-ENT Clinic 1. the Faculty of medicine and ENT

Clinic 2. the Faculty of Medicine (implants). This device may

the sum of the applied against health insurance companies in the Czech Republic, not more than

30 programmable cochlear any implantable systems,



for the treatment of intravenózními in) immunoglobulins (preparations included under

pharmaceutical group J06BA02-normal human immunoglobulins for i. v.-

Endobulin-85627, 85628 codes, codes, Flebogamma 97937-85513, 85514,

85515, 85516, Octagam-12691, 12692 codes, 1269 ^ 3) in the event of serious

agamaglulinémií granted 1. half of 2003 in health care

the establishments listed in the annex No. 19 of this Decree.



§ 3



(1) the health care provided by specialised therapeutic institutes shall be borne by the

under the contractual arrangement between the health insurance company and professional medical

the Institute



and) flat rate in annex No. 2), or



(b)) combined way according to annex 2 of part B)



(c) the performance by the way).



(2) the price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 1. half of the

2003. ^ 5)



(3) the value of the Director assigned to the point value of the relevant treatment

days referred to in the list of performance increases compared to the overhead of the contracted

These days in care 2. half of 2002 by 15 points, with the resulting

the value of the Director shall not be more than a list of performances.



(4) the flat-rate amount shall be reimbursed medicinal products pursuant to § 17 paragraph.

12 of the Act, shall be increased by $ 10, compared to the amount contracted by 2. half of the

2002.



(5) any other method of payment than provided for in paragraph 1, it is possible, if

Professional therapeutic Institute and health insurance on this method of payment

agreed, and this method is not in conflict with the law governing the

public health insurance.



(6) if the professional therapeutic Institute and the health insurance company will negotiate a supplement

to the contract, or out a new contract, containing new health

performances, provided by professional medical Institute, or negotiating a new

the structure provided by the health care, health insurance, these

in fact, the total amount of payments for 1. half of 2003 will include, if

This method is not in conflict with the law governing public

health insurance.



(7) the procedure for calculating the flat-rate remuneration and combined way, above

and conditions for reimbursement referred to in paragraph 1 (b). and (b))) and set out in annex

No 2 to this Decree.



§ 4



(1) the health care provided in hospitals for long-term patients,

under the contractual arrangement between the paid by the health insurance company and

medical facility under the performance remuneration for granted

health performance.



(2) the price point for the payment of health care referred to in paragraph 1, provided for the

1. half-year 2001 shall remain in force for 1. half-year 2003. ^ 6)



(3) the value of the Director assigned to the point value of the ošetřovacího of the day no. 00024

referred to in the list of performance increases compared to the contracted directed by this

ošetřovacího day of the 2. half of 2002 by 15 points, with the resulting value

Director shall not be more than a list of performances.



(4) the flat-rate amount shall be reimbursed medicinal products pursuant to § 17 paragraph.

12 of the Act, shall be increased by $ 10, compared to the amount contracted by 2. half of the

2002.



(5) any other method of payment than provided for in paragraph 1, it is possible, if

Sanatorium and health insurance in such a way

the remuneration agreed, and this method is not in conflict with the law

governing health insurance.



§ 5



(1) the health care provided in health facilities

returning the length of the day no. 00005 referred to in the list of performance shall be borne by

under the contractual arrangement between health insurance and health care

the device according to the performance remuneration for health.



(2) the price point for the payment of health care referred to in paragraph 1, provided for the

1. half-year 2001 shall remain in force for 1. half-year 2003. ^ 7)



(3) the value of the Director assigned to the spot value date no ošetřovacího. 00005

referred to in the list of performance increases compared to the contracted directed by this

ošetřovacího in 2. half of 2002 by 15 points, with the resulting

the value of the Director shall not be more than a list of performances.



(4) the flat-rate amount shall be reimbursed medicinal products pursuant to § 17 paragraph.

12 of the Act, shall be increased by $ 10, compared to the amount contracted by 2. half of the

2002.



(5) any other method of payment than provided for in paragraph 1, it is possible, if

medical facilities and health insurance on this method of payment

agreed, and this method is not in conflict with the law governing the

public health insurance.



§ 6



(1) the health care provided by the medical emergency services,

transport of the wounded, sick and expectant mothers, and medical services, first aid,

under the contractual arrangement between the paid by the health insurance company and

medical facilities



and) flat-rate, or



(b)) according to the list.



(2) any other method of payment than provided for in paragraph 1, it is possible, if

the total amount of the payment will be higher than the remuneration provided for in paragraph 1,

medical facilities and health insurance on this way

the remuneration agreed and this way will not be in conflict with the law

governing health insurance.



(3) the amount and conditions for reimbursement referred to in paragraph 1 shall be laid down in the annex No. 20

to this Decree.



section 7 of the



(1) the reimbursement of emergency health care, if there is no contract between the

medical facilities and health insurance, shall be carried out for the

health performance as follows:



and) dental out-patient care are reimbursed according to the rates in force for

health care provided by dentists in the 1. half of 2003,



(b)) other health care expenses shall be reimbursed in accordance with the list of performance and health

the undertaking may, on the basis of the law applied ^ 8) regulatory restrictions by analogy

as in the case of medical devices.



(2) the price point for the payment of health care referred to in paragraph 1 (b). (b))

set for 1. half of 2001 remains in force for 1. half of the

2003. ^ 9)



§ 8



(1) If, in the 1. half of 2003 will be the actual income of an insurance undertaking from the selection

insurance premiums after the redistribution is higher than the actual amount of the premium after the selection

redistribution in the 1. half of 2002, raises health insurance

a medical device referred to in section 1 (b). and (b))) and the total amount of

payment calculated in accordance with the procedure laid down in the annex to Decree No.

21 of this Decree.



(2) the revenue from the selection of premiums after the redistribution of data will be included

from the redistribution for the first through the sixth month of the year 2003.



(3) the increase referred to in paragraph 1 shall be reimbursed by health insurance contract

medical institutions to 30. November 2003.



(4) if in the course of the 1. half of 2003 to change the list of services will be

These changes in the calculation of the increase referred to in paragraph 1 is taken into account.



(5) the health insurance company to 31. October 2003, provide medical

device data on actual revenue from a selection of premium total after

redistribution for the 1. half of 2003.



(6) the provisions of § 8 paragraph. 1 to 5 shall apply to medical devices

referred to in section 1 (b). and), which at 1. half of 2003 provided the health

care in a volume of at least 98% of the comparable care compared to 1. half of 2002.

The volume of comparable care for a flat-rate remuneration is the number of unique

the treated policyholders, for remuneration according to the list of performance volume points for

declared and recognized by the performances.



(7) the provisions of § 8 paragraph. 1 to 5 shall apply to medical devices

referred to in section 1 (b). (b)), at 1. half of 2003 provided the health

care in a volume of at least 90% of the comparable care compared to 1. half of 2002.

The volume of comparable care for a flat-rate remuneration is the number of unique

the treated policyholders, for remuneration according to the list of performance volume points for

declared and recognized by the performances.



§ 9



This Decree shall take effect on 1 January 2005. January 1, 2003.



Secretary:



Mudr. Vishnu s in r.



Annex 1



Procedure for calculating the flat-rate, amount and conditions of payment according to § 2 (2). 1

(a). and (b)))



And the payment of flat-rate)



1. Reimbursement of health care provided by sleeper devices includes:



and acute care) remuneration reported on hospitalizačních accounts

including relevant performance complement (hereinafter referred to as the "hospital

remuneration "),
(b)) reimbursement of out-patient ambulatory care reporting on accounts, including

the relevant performance of the complement (hereinafter referred to as "ambulatory payment"),



(c) the reimbursement of transport performance), health (hereinafter referred to as "the remuneration of transport"),



(d) remuneration of other outputs) of health care, if the bed equipment

provides performance complement for other medical devices, where appropriate,

other contracted performances (hereinafter referred to as "other remuneration").



If any of these kinds of health care inpatient facilities

does not, then it is not part of the remuneration.



2. Procedure for the determination of a flat rate for 1. half-year 2003



The flat rate is calculated for each type of health care referred to in

point 1 (a). and (d))) of the amount of performance 1. half of 2002, which were

fasility reported and health insurance company recognized by 1. January

2002 to 30. November 2002, where appropriate, of the volume of previous performance

period, which have been recognised by the health insurance company, but were not counted

to the flat rate in previous periods, as follows:



The total volume of performances (and especially the points charged to medicinal products and

posted material) is divided by the number of unique treated policyholders,

who have been in inpatient facilities provided health care. Unique

the policyholder, which means a beneficiary, regardless,

How many times the bed on this device showed the insured person in specified

period of health care. Performances and unique treatment of insured persons are

be calculated separately for each type of remuneration referred to in paragraph 1 (b). and (d)).)



The flat rate includes:



and the number of points per 1) unique treated insured persons,



b) flat rate for a particularly charged, especially medicinal products posted

material and lékový fee on 1 unique treated insured persons, in

CZK.



2.1 the lump-sum rate of inpatient

sum sum BH ZH

PHB = -------- PHZ = -------

sum of the sum of the UH UH



where:



PHB = number of points per 1 insured persons per 1 unique treated. half of the

2002



BH = the number of points for all of the health operations while

hospitalization, including points for the category of a patient, for 1. half of 2002

the socket device, that have been reported and fasility

health insurance company recognized by 1. January 2002 to 30. November 2002,

In addition to the points:



and health performances) paid in 1. half of 2003 beyond blanket

the rates of inpatient or included in another flat-rate,



(b)) for the declared and recognized by the medical feats granted during hospitalization in

skills that are no longer for 1. half of 2003 contracted.



PHZ = flat rate for a particularly charged medicinal products, especially

posted material and a lékový fee provided in 1. half of 2002

the insured hospitalized on 1 unique treated policyholders.



ZH = payment for medicines, particularly charged separately billed

material and lékový fee provided in 1. half of 2002

hospitalized insured, who was banished and in-patient facilities

health insurance company recognized by 1. January 2002 to 30. November 2002,

In addition to the separately posted material and specifically charged the medicinal

products:



and covered in 1). half of 2003 beyond blanket rate of inpatient

or included in the other flat-rate,



(b) during hospitalization), provided in the fields of medicine, that are no longer for the

1. half of 2003 contracted.



UH = the number of unique treated insured persons, who have been in the 1. half of the

2002 hospitalized and their medical performances were provided by

the device reported and health insurance company recognized by 1. January 2002 to

November 30, 2002.



2.2 the flat rate for outpatient

sum sum for BA

PAB = ------- PAZ = -------

the sum of the sum of the UA UA



where:



PAB = number of points per 1 insured persons per 1 unique treated. half of the

2002.



BA = number of points for all of the performances in the dispensaries, health

for the 1. half of 2002 that were reported and health equipment Center

insurance recognised from 1. January 2002 to 30. November 2002, in addition to the points:



and health performances) paid in 1. half of 2003 beyond blanket

the rates of outpatient or included in another flat-rate,



(b)) for the declared and recognised health performances provided in dispensaries in

skills that are no longer for 1. half of 2003 contracted.



PAZ = flat rate for a particularly charged medicinal products and

posted material provided in 1. half of 2002 in ambulances treated

insurance policy holders on 1 unique treated policyholders.



A = remuneration for medicinal products particularly charged and billed separately

the material provided in the 1. half of 2002 in ambulances treated

the insured, who was banished and fasility health

insurance recognised from 1. January 2002 to 30. November 2002, in addition to the particularly

the posted material and separately charged of medicinal products:



and covered in 1). half of 2003 beyond blanket rate of outpatient

or included in the other flat-rate,



(b)) provided in the dispensaries in the fields of medicine, that are no longer for 1.

half of 2003 contracted.



UA = the number of unique treated insured persons, who have been in the 1. half of the

2002 in ambulances treated and provided health services

were reported and fasility health insurance company recognized by 1.

January 2002 to 30. November 2002.



2.3 the flat rate for medical transport

the sum of the BD sum ZD

PDB = -------- PDZ = -------

sum sum UD UD



where:



PDB = number of points per 1 insured persons per 1 unique treated. half of the

2002



BD = number of points for all of the health in health

transport in the 1. half of 2002 the registered devices, which have been

fasility reported and health insurance company recognized by 1. January

2002 to 30. November 2002, in addition to the points:



and health performances) paid in 1. half of 2003 beyond blanket

rates for medical transport or included in another flat-rate,



(b)) for the declared and recognised health performance provided in health

transport, that are no longer for 1. half of 2003 contracted.



PDZ = flat rate for a particularly charged medicinal products and

posted material provided in 1. half of 2002 in the medical transport

Coll., or treated the insured on 1 unique treated

the insured person.



ZD = remuneration separately charged medicinal products and separately billed

the material provided in the 1. half of 2002 in the medical transport

Coll., or treated the insured, who was patient

the device recorded and recognised health insurance from 1. January 2002 to 30.

November 2002, except in the separately posted material and separately charged

medicinal products:



and covered in 1). half of 2003 beyond blanket rate for the health

transport or included in the other flat-rate,



(b)) provided during performances in the medical transport, which are no longer for the

1. half of 2003 contracted.



UD = the number of unique treated insured persons, who have been in the 1. half of the

2002 in the medical transport, or transported and cared for them

health performance were reported and fasility

health insurance company recognized by 1. January 2002 to 30. November 2002.



2.4 the flat rate for other health performances

sum sum REV. BJ

PJB = -------- PJZ = --------

sum sum UJ UJ



where:



PJB = number of points per 1 insured persons per 1 unique treated. half of the

2002



BJ = number of points for all other health performance in the 1.

half of 2002 of the post operative care facilities that were fasility

reported and health insurance company recognized by 1. January 2002 to 30.

November 2002, in addition to the points:



and health performances) paid in 1. half of 2003 beyond blanket

the rates for other health performance or included in another flat-rate,



(b)) for the declared and recognised by other medical performance is provided in

skills that are no longer for 1. half of 2003 contracted.



PJZ = flat rate for a particularly charged medicinal products and

posted material provided in 1. half of 2002 when other health

performance of treated the insured on 1 unique treated policyholders.



ZJ = remuneration separately charged medicinal products and separately billed

the material provided in the 1. half of 2002 when other medical procedures

treated the insured, who was banished and fasility health

insurance recognised from 1. January 2002 to 30. November 2002, in addition to the particularly

the posted material and separately charged of medicinal products:



and covered in 1). half of 2003 beyond blanket rate for the other

health performance or included in the other flat-rate,



(b)) provided when other medical procedures in the fields of medicine, which

no longer for 1. half of 2003 contracted.



UJ = the number of unique treated policyholders, which were in the 1. half of the

2002 provided other health achievements that were fasility

reported and health insurance company recognized by 1. January 2002 to 30.

November 2002.



3. the calculation of the amount of the flat-rate payment for 1 point
When calculating the amount of the flat-rate payment for 1 point, based on the individual

the amount of the remuneration for the 1 point in 1. half of 2002, which regulates the

the differentiated increase in remuneration in 3 zones (described in section 3.2).



3.1 the individual amount of remuneration for the 1 point (IVUB). half of 2002

represents the proportion of the total remuneration without specifically charged the medicinal

products and especially the posted material on 1 point. Shall be determined in accordance with

the following formula:

the sum of PAYMENT 1. pol. 2002-from the 1. 2002.

IVUB = -------------------------------------------

the sum of POINTS 1. 2002.



where:



The PAYMENT of 1. 2002 =.



payment for all health services including category

the patient, provided by fasility in 1. half of 2002, which

were reported, recognized and cleared from the 1. January 2002 to 30. November

2002; This payment will not count towards the health services that are in the

1. half-year 2003 paid in excess of the flat-rate.



From the 1. 2002 =.



remuneration for medicinal products, and particularly charged separately posted material,

provided in the 1. half of 2002, which was banned and in-patient facilities

health insurance company recognized by 1. January 2002 to 30. November 2002; to

This remuneration shall not be charged separately charged medicinal products and

posted material that is in the 1. half-year 2003 paid in excess of the

flat rate.



POINTS 1. 2002 =.



the number of points for health and for the categories provided by the patient

in-patient facilities in 1. half of 2002 that were fasility

reported and health insurance company recognized by 1. January 2002 to 30.

November 2002; These points will not count towards points for health

the performances, which are 1. half-year 2003 paid in excess of the flat-rate.



3.2 the lump-sum payment for 1 item (PUB) for the 1. half of 2003 is based on the

individual amount of remuneration for 1 point, recorded a 1. half of 2002.

Shall be determined as follows:



and if the calculated IVUB) is less than $ 0.89 then PUB for 1.

half-year 2003 amounts to $, 0.89



(b)) if the calculated IVUB is equal to 0.89 Eur or less than or equal to 0.99

CZK, added to this IVUB 0.01 Kč (PUB = IVUB + 0.01)



(c)) if the calculated IVUB is equal to or higher than CZK 1, the

the calculated IVUB (PUB = IVUB)



(d) the calculated value for ancillary IVUB) under the flat-rate remuneration is paid in

the values calculated in accordance with point 3.2, subparagraph (a). and (c))) and is not limited.



4. the calculation of the total remuneration for provided health care



4.1 the lump-sum payment for different types of health care referred to in section 1

(a). and (d))) up to 1 unique treated the insured person is made up of

by multiplying the number of points on 1 unique treated the insured a lump

payment for 1 item (PUB) and by adding the volume of flat rates for particular

charged to the medicinal products and separately charged materials paid for 1

unique treated policyholders.



The calculation of the lump-sum payment to the insured for 1 unique treated

different types of health care referred to in point 1 (a). and (d))) up to 1.

half of 2003 is the following:



PHU = (PHB x PUB) + PHZ



PAU = (PAB x PUB) + PAZ



PDU = (PDB x PUB) + PDZ



PJU = (PJD x PUB) + PJZ



where:



PHU = lump sum payment on 1 unique inpatient treated

the insured's



PAU = standard outpatient reimbursement on 1 unique treated insured persons



PDU = flat-rate remuneration of transport on 1 unique treated insured persons



PJU = lump sum payment on the other 1 unique treated insured persons



4.2 payment for different types of health care referred to in point 1 (a). and)

(d)) shall be calculated so that the flat-rate payment on 1 unique treated

the insured person shall be multiplied by the number of unique treated policyholders in

the reporting period, as follows:



HU = PHU x UHV



AU = PAU x UAV



DU = PDU x UDV



JU = PJU x UJV



where:



HU = hospital reimbursement



AU = outpatient reimbursement



DU = transportation reimbursement



JU = other remuneration



UHV = the number of inpatients treated policyholders, whose unique

health care was provided, reported in 1. half of 2003 and recognised

health insurance company



UAV = the number of unique treated policyholders who were ambulatory

health care, reported in 1. half of 2003 and recognised

health insurance company



UDV = the number of unique treated policyholders who have been health

the right granted, reported in 1. half of 2003 and recognised health

the insurance company



UJV = the number of unique treated policyholders who were other performances

provided, shown in 1. half of 2003 and recognised health insurance



4.3 the total remuneration (CU) is the sum of the individual types of payments:



CU = HU + AU + DU + JU



Part of the total remuneration are on payment procedures under section 2 (2). 5.



5. Calculation of the remuneration in regulating the prescription of medicinal products and

medical devices



In the calculation of the total health care payments according to section 4.3 on

apply regulatory mechanisms, which are based on a comparison of average

the reimbursement of prescribed medicines and medical devices to 1

treated policyholders between 1. half of 2002 and 1. half of 2003. From

the comparison excludes medicinal products and medical devices

revision approved doctor or paid beyond the flat rate according to

§ 2 (2). 7.



5.1 in the event that the average payment for prescribed medicines and

medical devices on the 1-in-1 the insured person treated. half-year 2003

exceeds 105% of the average of the reference remuneration, which is made up of remuneration for

prescribed medicines and medical devices to 1 treated

insured persons in 1. half of 2002, the fixed reduction of 65% of the

total exceedances, which is calculated as the product of the number of treated

in the period and the amount of the cost overrun on medicinal products

and medical devices to 1 compared to 105% of the insured's treated

the average of the reference remuneration for medicinal products and medical

resources on 1 treated the insured person



5.2 If the average payment for prescribed medicines and medical

resources on 1 the insured person in the treated 1. half of 2003 reaches 100

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicinal products and medical devices to 1 the insured person treated in

1. half of the year 2002, the remuneration for the 1. half-year 2003 increased by 40%

the achieved savings. This saving is calculated as the product of the number of treated

in the period and amount of the costs to the Betterment of the medicinal

products and medical devices to 1 the insured compared to treated

100% of the average of the reference remuneration for medicinal products and medical

resources on 1 the insured person treated.



6. the provision of the monthly advance and the total amount of the remuneration of health care

flat rate



6.1 health insurance will provide the monthly advance in the lůžkovému device

the amount of one sixth 108% of the volume of remittances, including ZUM ZULP and covered by the above

framework of a flat rate, which have been paid for this lůžkovému device

1. half of the year 2002.



Monthly deposit from 1 January 2003 of 108% will be granted if

medical device filled with at least 98% of the volume of unique treated

policyholders in the 1. half of 2002, compared to 1. half of 2001.



If the volume of care medical equipment in the period 1. half of 2002

less than 98% of the volume of unique treated policyholders in the 1. half of the

2001, 108% of the backup are multiplied by the index:



I = (number of unique treated policyholders 1. half 2002)/(number of

unique treated policyholders 1. half of 2001)



If in individual months of 1. half of 2003 reports health

the higher the volume of the device points, than in the corresponding month of 1. half of 2002,

belongs to him for this month's advance of 108%.



Medical facilities and health insurance company may agree on

standing reserve 108% without those regulatory measures that reduce the

a fixed amount of the advance.



6.2 If, in the 1. half of 2003 fasility made care to 110

% of the number of unique treated policyholders including compared to 1. half of the

2002, will be used for the calculation of the remuneration of the number of unique treated

policyholders without reduction for each of the types of care, as they are listed in the

point 1, point (a). and (d))) up to annex No. 1 to this notice.



6.3 If the 1. half of 2003 fasility made care in

the span of more than 110% to 115% of the number of unique treated policyholders

including over 1. half of 2002, the number of unique treated

in this interval, multiplied by a coefficient of 0.75 for individual

types of care, as referred to in paragraph 1, point (a). and (d))) up to annex No. 1 to the

This Decree.



6.4 If the 1. half of 2003 fasility made care more

than 115% of the number of unique treated policyholders compared to 1. half of the

2002, the number of unique treated policyholders over 115% multiplied

coefficient of 0.40 for different types of care, as referred to in point 1,

(a). and (d))) up to annex No. 1 to this notice.



6.5. The total number of unique treated policyholders is the sum of

unique treated policyholders according to point 6.2 to 6.4.



4.1 until the negotiation of the price of the Appendix 1. half of 2003, up to a maximum
until 31 December 2006. 3. in 2003, the Center's medical facilities provided by the monthly

advance of 104% from 1/6 of the volume of financial resources correspond to

period, which is 1. half of 2002, including the increase of the remuneration referred to in article 14

Code No. 458/2001 Coll., laying down the amount of payments for health care

paid from public health insurance, including regulatory limitations

for the 1. half of 2002.



4.2 for the month in advance is due no later than 5. calendar

day of the following month.



(B) the remuneration referred to in the list of performance)



1.



Method of payment according to § 2 (2). 1 (a). (b)) may be applied only for the bed

the device, which is significantly fluctuating volume provided by the health care

paid from public health insurance, where it is not possible to establish

flat rate over the reference period because of the small number of treated

competent health insurance policyholders and where inpatient facilities in

average of one health insurance company charged more than 300 000 CZK

the calendar quarter.



2.



If the Contracting Parties agree, this variant can choose

the case of the higher volume of the Bill, however, must be met

significantly within the volume of the provided health care.



3.



Health care provided by the medical establishment has strongly unstable

the volume if the volume of reported health care for the individual

of the month at 1. half-year 2002 differed at least in one case, more than 25

%.



Annex 2



Procedure for calculating the flat-rate remuneration and combined way, above and

conditions for reimbursement under section 3 (3). 1 (a). and (b)))



And the payment of flat-rate)



Monthly payment amounts to 108% of the comparison of the volume of payments. Comparison

amount of reimbursement is equal to 1/12 of payments for health care provided in

2002, and the comparison of the volume is not remuneration for

provided health care in the comparison period, in cases where this

the care is no longer in the treatment provided to the Institute, or is paid

otherwise.



1. Conditions of payment and the amount of the



1.1 Payment in the amount of 108% belongs only on the condition that the reported number of

care days in the 1. half-year 2003 amounts to at least 98% of the number of

care days reported in 1. half of 2002. In the event that the professional

therapeutic Institute reports less than 98% of care days provided for,

will be provided for the total lump-sum rate for 1. half of 2003 under the bed

care has been reduced by a percentage (fixed to two decimal places), for which

was not filled with the established limit on the number of care days.



Monthly deposit from 1. 1.2003 of 108% will be granted if

medical device filled with at least 98% of the volume of unique treated

policyholders in the 1. half of 2002, compared to 1. half of 2001.



If the volume of care medical equipment in the period 1. half of 2002

less than 98% of the volume of unique treated policyholders in the 1. half of the

2001, 108% of the backup are multiplied by the index:



I = (number of unique treated policyholders 1. half 2002)/(number of

unique treated policyholders 1. half of 2001)



If in individual months of 1. half of 2003 reports health

the higher the volume of the device points, than in the corresponding month of 1. half of 2002,

belongs to him for this month's advance of 108%.



Medical facilities and health insurance company may agree on

standing reserve 108% without those regulatory measures that reduce the

a fixed amount of the advance.



1.2 If the 1. half of 2003 Professional Medical Institute carried out taking care

the 110% the number of treatment days including compared to 1. half of 2002, the

made the payment within the specified amount of 108%.



1.3 If the 1. half of 2003 Professional Medical Institute carried out taking care

in the span of more than 110% to 115% of the number of treatment days including compared

1. half of the year 2002, the number of care days in this interval multiplied

a coefficient of 0.75.



1.4 If 1. half of 2003 Professional Medical Institute carried out taking care

more than 115% of the number of care days, compared to 1. half of 2002, the

the number of care days of over 115% multiplied by a coefficient of 0.40.



1.5 payment is the sum of the total amount from 1.2 to 1.4.



by the time of the negotiation of the price to 1.6 of Appendix 1. half of 2003, up to a maximum

until 31 December 2006. 3. in 2003, the Center's medical facilities provided by the monthly

advance of 104% of 1/12 of the volume of financial resources correspond to

period, which is the year of 2002, including an increase in remuneration in accordance with section 14 of the code no.

458/2001 Sb.



1.7 for the month in advance is due no later than 5. calendar

day of the following month.



2. the calculation of the remuneration in regulating the prescription of medicinal products and

medical devices



Regulatory mechanisms are based on a comparison of the average remuneration for

prescribed medicines and medical devices to 1 treated

insured persons between 1. half of 2002 and 1. half of 2003. A comparison of the

exclude medicinal products and medical devices approved by the audit

doctor.



2.1. In the case that the average payment for prescribed medicines and

medical devices on the 1-in-1 the insured person treated. half-year 2003

exceeds 105% of the average of the reference remuneration, which is made up of remuneration for

prescribed medicines and medical devices to 1 treated

insured persons in 1. half of 2002, the fixed reduction of 65% of the

total exceedances, which is calculated as the product of the number of treated

in the period and the amount of the cost overrun on medicinal products

and medical devices to 1 compared to 105% of the insured's treated

the average of the reference remuneration for medicinal products and medical

resources on 1 the insured person treated.



2.2 If the average payment for prescribed medicines, medical

resources on 1 the insured person in the treated 1. half of 2003 reaches 100

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicinal products and medical devices to 1 the insured person treated in

1. half of the year 2002, the remuneration for the 1. half-year 2003 increased by 40%

the achieved savings. This saving is calculated as the product of the number of treated

in the period and amount of the costs to the Betterment of the medicinal

products and medical devices to 1 the insured compared to treated

100% of the average of the reference remuneration for medicinal products and medical

resources on 1 the insured person treated.



(B) payment of combined way)



A combined method of payment will be used for specialized therapeutic institutes, which

they have contracted in health care bed only performances of the type of care

day, or performances, which show the receipt and discharge

examination of the list of performances.



1. Reimbursement of inpatient care



1.1 Inpatient care will be paid for by payment for day care and for performances,

which show the receipt and examinations referred to in the list of the layoff

performances with the price point according to § 3 (2). 2.



Monthly deposit from 1. 1.2003 of 108% will be granted if

medical device filled with at least 98% of the volume of unique treated

policyholders in the 1. half of 2002, compared to 1. half of 2001.



If the volume of care medical equipment in the period 1. half of 2002

less than 98% of the volume of unique treated policyholders in the 1. half of the

2001, 108% of the backup are multiplied by the index:



I = (number of unique treated policyholders 1. half 2002)/(number of

unique treated policyholders 1. half of 2001)



If in individual months of 1. half of 2003 reports health

the higher the volume of the device points, than in the corresponding month of 1. half of 2002,

belongs to him for this month's advance of 108%.



Medical facilities and health insurance company may agree on

standing reserve 108% without those regulatory measures that reduce the

a fixed amount of the advance.



1.2 If the 1. half of 2003 Professional Medical Institute carried out taking care

the 110% the number of treatment days including (including performance, which

reported income and layoff) compared to 1. half of 2002,

payment will be performed within a specified amount of 108%.



1.3 If the 1. half of 2003 Professional Medical Institute carried out taking care

in the span of more than 110% to 115% of the number of treatment days (including

the performance, which show the receipt and discharge examination) including

compared to the 1. half of 2002, the number of care days at this interval

multiplied by a coefficient of 0.75.



1.4 If 1. half of 2003 Professional Medical Institute carried out taking care

more than 115% of the number of treatment days (including performance, which

reported income and layoff) compared to 1. half of 2002,

the number of care days of over 115% multiplied by a coefficient of 0.40.



1.5 payment of the total amount of inpatient care is the sum according to point 1.2 to 1.4.



by the time of the negotiation of the price to 1.6 of Appendix 1. half of 2003, up to a maximum

until 31 December 2006. 3. in 2003, the Center's medical facilities provided by the monthly

advance of 104% of 1/12 of the volume of financial resources correspond to

period, which is the year of 2002, including an increase in remuneration in accordance with section 14 of the code no.

458/2001 Sb.



1.7 for the month in advance is due no later than 5. calendar

day of the following month.
2. Reimbursement of ambulatory care, medical transportation and other health

performance



Out-patient care, health, transportation and other performances will be

be covered by a flat rate, which is calculated from the volume of performance 1. half of the

2002, which were professional therapeutic Institute reported and health

insurance recognised from 1. January 2002 to 30. November 2002, where appropriate, of

the previous period volume of performances that were health insurance

recognized, but not included in the flat rate in previous periods,

as follows:



The total volume of health performance (especially the healing post points

preparations and posted material) is divided by the number of unique

insured persons who have been treated in the specialized treatment of the Institute granted

health care. Unique products treated with the policyholder shall mean one

beneficiary, regardless of how many times the professional therapeutic Institute reported on

of the insured person within a specified period of time health care. Performances and

the unique treatment of insured persons shall be calculated separately for outpatient care,

medical services and other medical procedures.



The flat rate includes:



and the number of points per 1) unique treated insured persons,



b) flat rate for a particularly charged, especially medicinal products posted

material and lékový fee on 1 unique treated policyholders in CZK.



2.1 the lump-sum rate of outpatient

sum sum for BA

PAB = --------- PAZ = ---------

the sum of the sum of the UA UA



where:



PAB = number of points per 1 insured persons per 1 unique treated. half of the

2002



BA = number of points for all of the health in the dispensaries in

1. half 2002 of vocational treatment Institute, that have been reported

and recognised from 1. January 2002 to 30. November 2002, in addition to the points:



and health performances) paid in 1. half of 2003 beyond blanket

the rates of outpatient or included in another flat-rate,



(b)) for the declared and recognised health performances provided in dispensaries in

skills that are no longer for 2. half of 2003 contracted.



PAZ = flat rate for a particularly charged medicinal products and

posted material provided in 1. half of 2002 in ambulances treated

insurance policy holders on 1 unique treated policyholders.



A = remuneration for medicinal products particularly charged and billed separately

the material provided in the 1. half of 2002 in ambulances treated

the insured, who was banished and recognised from 1. January 2001 to 30.

November 2002, except in the separately posted material and separately charged

medicinal products:



and covered in 1). half of 2003 beyond blanket rate of outpatient

or included in the other flat-rate,



(b)) provided in the dispensaries in the fields of medicine, that are no longer for 1.

half of 2003 contracted.



UA = the number of unique treated insured persons, who have been in the 1. half of the

2002 in ambulances treated and health performances have been recognized and accepted

from the 1. January 2002 to 30. November 2002.



2.2 the flat rate for medical transport

the sum of the BD sum ZD

PDB = -------- PDZ = --------

sum sum UD UD



where:



PDB = number of points per 1 insured persons per 1 unique treated. half of the

2002



BD = number of points for all of the health in health

transport in the 1. half of 2002 the Institute of vocational treatment, which

have been reported and recognized by 1. January 2002 to 30. November 2002, in addition to

points:



and health performances) paid in 1. half of 2003 beyond blanket

rates for medical transport or included in another flat-rate,



(b)) for the declared and recognised health performance provided in health

transport, that are no longer for 1. half of 2003 contracted.



PDZ = flat rate for a particularly charged medicinal products and

posted material provided in 1. half of 2002 in the medical transport

Coll., or treated the insured on 1 unique treated

the insured person.



ZD = remuneration separately charged medicinal products and separately billed

the material provided in the 1. half of 2002 in the medical transport

Coll., or treated the insured, who was banished and recognised

from the 1. January 2002 to 30. November 2002, except in the separately posted

material and separately charged of medicinal products:



and covered in 1). half of 2003 beyond blanket rate for the health

transport or included in the other flat-rate,



(b)) provided during performances in the medical transport, which are no longer for the

1. half of 2003 contracted.



UD = the number of unique treated insured persons, who have been in the 1. half of the

2002 health transport or transported, treated and health

the performances were recorded and recognised from 1. January 2002 to 30. November 2002.



2.3 the flat rate for other health performances

sum sum REV. BJ

PJB = ------- PJZ = -------

sum sum UJ UJ



where:



PJB = number of points per 1 insured persons per 1 unique treated. half of the

2002



BJ = number of points for all other health performance in the 1.

half of 2002 the Institute of vocational treatment that have been reported and

recognised from 1. January 2002 to 30. November 2002, in addition to the points:



and health performances) paid in 1. half of 2003 beyond blanket

the rates for other health performance or included in another flat-rate,



(b)) for the declared and recognised by other medical performance is provided in

skills that are no longer for 1. half of 2003 contracted.



PJZ = flat rate for a particularly charged medicinal products and

posted material provided in 1. half of 2002 when other health

performance of treated the insured on 1 unique treated policyholders.



ZJ = remuneration separately charged medicinal products and separately billed

the material provided in the 1. half of 2002 when other medical procedures

treated the insured, who was banished and recognised from 1. January 2002 to

November 30, 2002, in addition to the separately posted material and especially

posted in medicinal products:



and covered in 1). half of 2003 beyond blanket rate for the other

health performance or included in the other flat-rate,



(b)) provided when other medical procedures in the fields of medicine, which

no longer for 1. half of 2003 contracted.



UJ = the number of unique treated policyholders, which were in the 1. half of the

2002 provided other health achievements that have been recognized and acknowledged by

1 January 2002 to 30. November 2002.



3. Calculation of the remuneration for health care



3.1 the lump-sum payment for outpatient care, health services and other

health performance on 1 unique treated the insured person is made up of

by multiplying the number of points on 1 unique treated the insured a lump

remuneration for 1 point and by adding the volume of flat rates for a particularly charged

medicinal products and separately charged materials paid on 1 unique

treated policyholders.



The calculation of the lump-sum payment to the insured for 1 unique treated

different types of health care for 1. half of 2003 is the following:



PAU = (PAB x CB) + PAZ



PDU = (PDB x CB) + PDZ



PJU = (PJB x CB) + PJZ



where:



PAU = standard outpatient reimbursement on 1 unique treated insured persons



PDU = flat-rate remuneration of transport on 1 unique treated insured persons



PJU = lump sum payment on the other 1 unique treated insured persons



CB = price of item according to § 3 (2). 2.



3.2 payment for outpatient care, health services and other health

performance is calculated so that the flat-rate payment shall be multiplied by the number of

unique treated policyholders in the reporting period, as follows:



AU = PAU x UAV



DU = PDU x UDV



JU = PJU x UJV



where:



AU = outpatient reimbursement



DU = transportation reimbursement



JU = other remuneration



UAV = the number of unique treated policyholders who were ambulatory

health care, reported in 1. half of 2003 and recognised

health insurance company



UDV = the number of unique treated policyholders who have been health

the right granted, reported in 1. half of 2003 and recognised health

the insurance company



UJV = the number of unique treated policyholders, to whom the other performances

provided, shown in 1. half of 2003 and recognised health insurance



3.3 the total remuneration (CU) is the sum of the individual types of payments:

CU = AU + DU + JU



Part of the total remuneration are on payment procedures under section 3 (3). 6.



4. the calculation of the remuneration in regulating the prescription of medicinal products and

medical devices



In the calculation of the total health care payments according to section 3.3 shall be further

apply regulatory mechanisms, which are based on a comparison of average

the reimbursement of prescribed medicines and medical devices to 1

treated policyholders between 1. half of 2002 and 1. half of 2003. From

the comparison excludes medicinal products and medical devices

revision approved by the doctor.



4.1 in the event that the average payment for prescribed medicines and

medical devices on the 1-in-1 the insured person treated. half-year 2003

exceeds 105% of the average of the reference remuneration, which is made up of remuneration for

prescribed medicines and medical devices to 1 treated

insured persons in 1. half of 2002, the fixed reduction of 65% of the
total exceedances, which is calculated as the product of the number of treated

in the period and the amount of the cost overrun on medicinal products

and medical devices to 1 compared to 105% of the insured's treated

the average of the reference remuneration for medicinal products and medical

resources on 1 the insured person treated.



4.2 If the average payment for prescribed medicines, medical

resources on 1 the insured person in the treated 1. half of 2003 reaches 100

% of the average of the reference remuneration, which is made up of remuneration for prescribed

medicinal products and medical devices to 1 the insured person treated in

1. half of the year 2002, the remuneration will be for 1. half-year 2003 increased by 40%

the achieved savings. This saving is calculated as the product of the number of treated

in that period, and the Betterment of the cost of medicinal products and

medical devices to 1 compared to 100% of the insured's treated

the average of the reference remuneration for medicinal products and medical

resources on 1 the insured person treated.



Annex 3



A list of bed establishments-center for the treatment of chronic pain

States

+---+---------+----------------------------------+---------+

|č. | CORPORATE ID | The name of the registered equipment | Head Office |

+---+---------+----------------------------------+---------+

' |1 '. | 00023884 | Homolce Hospital | Prague 5 |

+---+---------+----------------------------------+---------+

|2. | 00064203 | Teaching hospital in motol | Prague 5 |

+---+---------+----------------------------------+---------+

| 3. | 61,383,082 | Central military hospital Prague | Prague 6 |

+---+---------+----------------------------------+---------+

| 4. | 00159816 | The University Hospital. Anna | Brno |

+---+---------+----------------------------------+---------+

| 5. | 65,269,705 | Faculty hospital Brno | Brno |

+---+---------+----------------------------------+---------+

| 6. | 00098892 | Faculty hospital Olomouc | Olomouc 5 |

+---+---------+----------------------------------+---------+



Annex 4



List separately charged, medicinal products for treatment of hemophilia

-------------------------------------------------------------------

ATC Code the name of the add-in name

-------------------------------------------------------------------

PROTHROMPLEX TOTAL TIM 86657 B02BD01 4 200I. E INJ SIC 1X200UT + SOL

PROTHROMPLEX TOTAL TIM B02BD01 75634 4 600I. E INJ SIC 1X600UT + SOL

-------------------------------------------------------------------

B02BD02 53360 ANTIHEM. (F). (HUMAN), SIC HEMOFIL M INJ 1X1000UT + SAT

93006 B02BD02 ANTIHEM. (F). (HUMAN), SIC HEMOFIL M INJ 1X250UT + SOL

53359 B02BD02 ANTIHEM. (F). (HUMAN), SIC HEMOFIL M INJ 1X500UT + SOL

87240 B02BD02 FANHDI 1000 IU INJ SIC 1X1KU + SOLV.

87238 B02BD02 FANHDI 250 IU INJ SIC 1X250UT + SOL

87239 B02BD02 FANHDI 500 IU INJ SIC 1X500UT + SOL

B02BD02 60381 HAEMOCTIN SDH INJ SIC 1000 1X1KU + SOLV.

B02BD02 60379 HAEMOCTIN SDH 250 INJ SIC 1X250UT + SOL

B02BD02 60380 HAEMOCTIN SDH INJ 500 SIC 1X500UT + SOL

89029 B02BD02 IMMUNATE STIM PLUS 1000 INJ SIC 1X1KU + SOLV.

89027 B02BD02 IMMUNATE STIM PLUS 250 INJ SIC 1X250UT + SOL

89028 B02BD02 IMMUNATE STIM PLUS 500 INJ SIC 1X500UT + SOL

B02BD02 58700 OCTANATE 1000 INJ SIC 1X1000UT + SOL

B02BD02 58278 OCTANATE 250 I.U. INJ SIC 1 x 250 UT + SOL

B02BD02 58279 OCTANATE 500 I.U. INJ SIC 1X500 UT + SOL

B02BD02 10747 REFACTO 1000 I.E. PSO 1X1KU LQF INJ

B02BD02 10745 REFACTO 250 I.E. PSO 1X250UT LQF INJ

10746 REFACTO B02BD02 500 I.E. PSO 1X500UT LQF INJ

88335 B02BD02 HAEMATE P INJ SIC 1 x 250UT

88336 B02BD02 HAEMATE P INJ SIC 1X500UT

88337 B02BD02 HAEMATE P INJ SIC 1X1KU

-------------------------------------------------------------------

85677 B02BD03 FEIBA TIM 4 1000 J. INJ SIC 1X1KU + SOLV.

85676 B02BD03 FEIBA TIM 4 500 J. INJ SIC 1X500UT + SOL

-------------------------------------------------------------------

B02BD04 75080 IMMUNINE 1200 I.E. INJ SIC 1.2 to + 10

B02BD04 75079 IMMUNINE 600 I.E. INJ SIC 1X600UT + 5

B02BD04 OCTANINE F 1000 57481 INJ PSO LQF 1X1KU

B02BD04 OCTANINE F 250 57468 INJ PSO LQF 1X250UT

B02BD04 OCTANINE F 500 57477 INJ PSO LQF 1X500UT

-------------------------------------------------------------------

B02bd08 89826 NOVOSEVEN 120 KIU (1.5 MG) INJ SIC 1 x 2.4 MG + SOL

B02bd08 58496 NOVOSEVEN 120KIU (1.5 MG) INJ SIC 2.4 MG + 10 STR

B02bd08 92641 NOVOSEVEN 240KIU (3.0 MG) INJ SIC 1 x 4.8 MG + SOL

B02bd08 58497 NOVOSEVEN 240KIU (3.0 MG) INJ SIC 4.8 MG + 10 STR

B02bd08 58495 NOVOSEVEN 60KIU (1.2 MG) INJ SIC 1.2 MG + 10 STR

B02bd08 89825 NOVOSEVEN 60KIU (1.2 MG) INJ SIC 1 x 1.2 MG + SOL

-------------------------------------------------------------------



Annex 5



The list of selected inpatient facility-center for the treatment of HIV/AIDS

+---+---------+-------------------------+----------------+--------------------+

|č. | CORPORATE ID | The name of the registered equipment | Head Office | The workplace |

+---+---------+-------------------------+----------------+--------------------+

' |1 '. | 65,269,705 | Faculty hospital Brno | Brno-Bohunice | clinic infectious |

| | | | | diseases |

+---+---------+-------------------------+----------------+--------------------+

|2. | 00179906 | University Hospital | Hradec Králové | infectious |

| | | | | Clinic |

+---+---------+-------------------------+----------------+--------------------|

| 3. | 00843989 | University Hospital | Ostrava-Poruba | clinic for treatment |

| | | first | infectious diseases ' | |

| | | | | & AIDS |

+---+---------+-------------------------+----------------+--------------------+

| 4. | 00669806 | University Hospital | Pilsen | AIDS Center |

| | | | infectious diseases clinic | |

+---+---------+-------------------------+----------------+--------------------+

| 5. | 00064211 | University Hospital | Prague 8 | AIDS Center |

| | | Na | infectious diseases clinic | |

+---+---------+-------------------------+----------------+--------------------+

| 6. | 00673544 | Masaryk hospital | Ústí nad Labem | Department of portable |

| | | first | | diseases |

+---+---------+-------------------------+----------------+--------------------+

| 7. | 00072711 | Hospital České Budějovice Czech | | infectious Department |

| | | České Budějovice | | Hospital |

+---+---------+-------------------------+----------------+--------------------+



Annex 6



Antiretroviral medicinal products and medicinal products for comprehensive treatment

opportunistic infections in patients with HIV/AIDS

--------------------------------------------------------------------------

ATC Code the name of the add-in name

--------------------------------------------------------------------------

J01CA12 PIPRIL 2GM 94251 INJ SIC 1X2GM

J01CA12 PIPRIL 4GM INF 58182 SIC 1X4GM

J01CA12 PIPRIL 4GM 94252 INJ SIC 1X4GM



J01CR02 72972 AMOKSIKLAV 1.2 GM INJ SIC 5 x 1.2 GM

J01CR02 05951 AMOKSIKLAV 1 g TBL OBD 14X1GM

J01CR02 85524 AMOKSIKLAV 375MG TBL OBD 21X375MG

J01CR02 72973 5X600MG 600 mg SIC AMOKSIKLAV INJ

J01CR02 97660 AUGMENTIN 1.2 G INJ SIC 5 x 1.2 GM

J01CR02 66020 AUGMENTIN 1.2 GM INJ SIC 10 x 1.2 GM

J01CR02 92207 AUGMENTIN 1.2 GM INJ SIC 5 x 1.2 GM

J01CR02 600 mg AUGMENTIN 92206 INJ SIC 10X600MG

J01CR02 CURAM 53577 625MG TBL OBD 21X625MG



J01CR03 93169 TIMENTIN 1.6 GM INJ SIC 4 x 1.6 GM

J01CR03 93170 TIMENTIN 3.2 GM INJ SIC 4 x 3.2 GM



J01CR05 TAZOCIN 2.25 GM 84783 INJ SIC 1 x 2.25 GM

J01CR05 TAZOCIN 4.5 GM 84784 INJ SIC 1 x 4.5 GM



J01DA 94756 2GM SULPERAZON IM/IV INJ SIC 1 x (1GM + 1GM)



J01DA10 CEFOTAXIME 94176 LEK INJ 1GM SIC 1X1GM

J01DA10 93715 CLAFORAN INJ 1X1GM

J01DA10 11354 CLAFORAN 1.0 G I.V., I.M. INJ SIC 1X1GM

J01DA10 SEFOTAK 53235 0.5 GM INJ SIC 1 x 0.5 GM + SOL

J01DA10 SEFOTAK 1GM 53236 INJ SIC 1X1GM + SOLV.

J01DA10 INJ TAXCEF SIC 1X1GM 05770

05768 J01DA10 TAXCEF INJ SIC 1X500MG

J01DA10 TAXCEF 2 g 05748 INJ SIC 1X2GM



J01DA11 76353 1 g 1X1GM FORTUM INJ SIC

J01DA11 76354 FORTUM 2 g INJ SIC 1X2GM

J01DA11 76355 FORTUM INJ 500 mg SIC 1X500MG



J01DA13 CEFTRIAXONE-01645 1000 SL INJ SIC 5X1GM

J01DA13 01649 CEFTRIAXONE 2000-SL INF SIC 1X2GM

J01DA13 01648 CEFTRIAXONE 2000-SL INJ SIC 5X2GM

01647 J01DA13 CEFTRIAXONE 500-SL INJ SIC 5 x 0.5 GM

J01DA13 LENDACIN 1 g INJ 80662 SIC 5X1GM

J01DA13 NOVOSEF 1 g 54086 I.M. INJ SIC 1X1GM + SOLV.

J01DA13 NOVOSEF 1 g I.V. 54085 INJ SIC 1X1GM + SOLV.



J01DA23 76233 SUPRAX TBL OBD 10X200MG



87199 J01DA24 MAXIPIME 1 GM INJ SIC 1X1GM

87200 J01DA24 MAXIPIME 2 GM INJ SIC 1X2GM

87198 J01DA24 MAXIPIME INJ 500 mg SIC 1X500MG



J01DA32 75039 CEFOBID 1 GM INJ SIC 1X1GM



86699 J01DA37 CEFROM 1GM INJ SIC 1X1GM



86412 J01DF01 AZACTAM 1 G INJ SIC 1X1GM



J01DH02 83417 MERONEM INJ SIC 10X1GM



J01EE01 11706 BISEPTOL 480 INJ 10X5ML

J01EE01 75023 COTRIMOXAZOL AL FORTE TBL 20X960MG

J01EE01 PRIMOTREN 91281 INJ 10X5ML



J01FF01 98212 DALACIN C INJ 3X6ML/900MG

J01FF01 DALACIN C 150 mg 91193 CPS 100X150MG

J01FF01 97878 KLIMICIN INJ 10X2ML/300 mg

J01FF01 64630 KLIMICIN INJ 10X4ML/600 mg



J01FF02 01835 1X2ML/600 mg LINCOCIN INJ

J01FF02 NELOREN 91997 CPS 16X500MG

J01FF02 97565 NELOREN INJ 10X2ML/600 mg



J01GB03 96413 GENTAMICIN LEK 40 mg/2 ml INJ 10X2ML/40 mg

J01GB03 96414 GENTAMICIN 80 mg/2 ml LEK INJ 10X2ML/80 mg
J01GB06 11785 AMIKIN INJ 1 G 1X4ML/1GM

J01GB06 03951 AMIKIN 100 mg 1X2ML/INJ 100 mg

J01GB06 03952 1X2ML/AMIKIN INJ 500 mg 500 mg



J01GB07 NETROMYCINE 200 mg/2 ml 90485 INJ 1X2ML/200 mg

J01GB07 NETROMYCINE 400 mg/2 ml 83736 INJ 1X2ML/400 mg



J01MA01 OFLOXIN INF INF 66137 1X100ML/200 mg

92740 TARIVID Iv 200 J01MA01 INF 5X100ML/200 mg

J01MA01 ZANOCIN 200 mg TBL 12349 OBD 10X200MG



J01MA02 53715 CIFLOXINAL TBL OBD 200X250MG

J01MA02 CIPHIN for 53922

200 mg/100 ml INFUSION BROTH POWDER. INF 1X100ML/200 mg

J01MA02 CIPHIN for INFUSIONE 53921

100 mg/50 ml INF 1X50ML/100 mg

J01MA02 56830 CIPLOX INF 1X100ML (plastic)

J01MA02 44986 CIPLOX 500 TBL OBD 50X500MG

J01MA02 96040 CIPRINOL 100 mg/10 ml INF 5X10ML/100 mg

J01MA02 100 mg/50 ml 59829 CIPRINOL INF 1X50ML/100 mg

J01MA02 59830 CIPRINOL 200 mg/100 ml 1X100ML INF/200 mg

86636 J01MA02 CIPROBAY 100 INF 5X50ML/100 mg

86637 J01MA02 CIPROBAY INF 5X100ML/200 mg



J01MA03 ABAKTAL 94155 INJ 10X5ML/400 mg

J01MA03 94156 ABAKTAL TBL OBD 10X400MG



J01XA01 92289 EDICIN 0.5 GM INJ SIC 1X500MG

J01XA01 1GM EDICIN 92290 INJ SIC 1X1GM

J01XA01 01619 VANCOCIN CP 500 mg INJ SIC 1X500MG



05114 TARGOCID INJ 200 mg of J01XA02 SIC 1X200MG + SOL

J01XA02 05113 TARGOCID 400 mg INJ SIC 1X400MG + SOL



J02AA01 44141 ABELCET INF 10X10ML/50 mg

44148 10X10ML J02AA01 ABELCET INF/50 mg

44142 10X20ML J02AA01 ABELCET INF/100 mg

J02AA01 44149 ABELCET INF 10X20ML/100 mg

32144 AMPHOCIL J02AA01 100 mg INF PLV SOL 10X100MG

32142 AMPHOCIL J01AA01 50 mg INF PLV SOL 10X50MG

J02AA01 AMPHOTERICIN B INJ 57548 SQUIBB SIC 1X50MG



J02AC01 DIFLAZON 1X100ML/INF 58431 200 mg

64946 DIFLUCAN J02AC01 I.V. INF 1X100ML 2 mg/ML

J02AC01 46979 FLUCONAZOL-SLOVAKOFARMA

For INF INF 1X100ML/200 mg

66036 J02AC01 MYCOMAX 100 CPS 28X100MG

65989 INF INF J02AC01 MYCOMAX 1X100ML/200 mg

J02AC01 59872 MYCOSYST INF 10X100ML 2 mg/ML

J02AC01 59871 MYCOSYST INF 1X100ML 2 mg/ML



J02AC02 58872 SPORANOX POR CPS DUR28X100MG



J05AB01 KUMAR 250 93260 INF SIC 10X250MG

J05AB01 53610 XOROX 400 mg TBL 60X400MG

J05AB01 53611 800MG 35X800MG XOROX TBL

J05AB01 250 mg ZOVIRAX 64953 INJ SIC 5X250MG

J05AB01 64952 ZOVIRAX 500 mg INJ SIC 5X500MG



02064 CYMEVENE INF J05AB06 SIC 1X500MG

J05AB06 250 mg 59653 CYMEVENE POR CPS MAJOR 84X250MG



J05AB11 30236 VALTREX 500 mg TBL OBD 42X500MG



J05AD01 24MG/ML 62698 FOSCAVIR INF 1X250ML



J05AE01 55688 INVIRASE CPS 270X200MG

J05AE01 59463 FORTOVASE 200 mg CPS 360X400MG



J05AE02 44124 CRIXIVAN 200 CPS 360X200MG

J05AE02 44126 CRIXIVAN 400 CPS 180X400MG



J05AE03 57784 NORVIR CPS 2X84 = 168X100MG



86100 J05AF01 RETROVIR INF CNC 5X20ML/200 mg

J05AF01 58729 RETROVIR 100 CPS 100X100MG

J05AF01 58728 RETROVIR 250 CPS 40X250MG



J05AF02 57422 VIDEX 100 mg CTB 60X100MG

J05AF02 150 mg 57423 VIDEX CTB 60X150MG



J05AF03 0.375 MG HIVID 66733 TBL 100 x 0.375 MG. OBD-B

J05AF03 66734 HIVID 0.75 MG TBL 100 x 0.75 MG. OBD-B



J05AF04 53209 ZERIT 40 mg CPS 56X40MG



J05AF05 47158 EPIVIR TBL OBD 60X150MG

J05AF05 02086 ZEFFIX 100 mg TBL OBD 84X100MG



J05AF06 58396 ZIAGEN TBL OBD 60X300MG



57852 OBD J05AF30 TBL 60 COMBIVIR (BLISTER)

J05AF30 TBL 60 COMBIVIR 59221 OBD (the.)



J05AG01 57777 VIRAMUNE TBL 60X200MG



J05AG03 200 mg STOCRIN 59948 CPS 90X200MG



B03XA01 85530 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.2 ML/3KU

B03XA01 85531 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/4KU

B03XA01 57340 EPREX 1000 IU/0.1 ML 6 x 0.5 ML INJ SOL/5KU

B03XA01 57341 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/6KU

B03XA01 57342 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/7KU

B03XA01 57343 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.5 ML/8KU

B03XA01 57344 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/9KU

B03XA01 85532 EPREX 1000 IU/0.1 ML INJ SOL 6X1ML/10KU

B03XA01 85528 EPREX 200 IU/0.1 ML 6 x 0.5 ML INJ SOL/1KU

B03XA01 93579 EPREX 200 IU/0.1 ML INJ SOL 6X1ML/2KU

B03XA01 02267 EPREX 40, 000 INJ SOL 1X1ML/40KU

B03XA01 85529 EPREX 400 IU/0.1 ML 6 x 0.5 ML INJ SOL/2KU

B03XA01 58451 NEORECORMON 10 000 IU INJ SOL 6 x 0.6 ML/10KU

B03XA01 64816 NEORECORMON 1000 IU INJ SOL 6 x 0.2 ML/1KU

B03XA01 58453 NEORECORMON 20 000 IU INJ SOL 6 x 0.6 ML/20KU

B03XA01 64812 NEORECORMON 2000 IU INJ SOL 6 x 0.2 ML/2KU

B03XA01 64818 NEORECORMON 3000 IU INJ SOL 6 x 0.2 ML/3KU

B03XA01 06221 NEORECORMON 4000IU INJ SOL 6 x 0.2 ML/4KU

B03XA01 64814 NEORECORMON 500 IU INJ SOL 6 x 0.2 ML/500UT

B03XA01 58449 NEORECORMON 5000 IU INJ SOL 6 x 0.2 ML/5KU

B03XA01 58686 NEORECORMON

MULTIDOSE 100,000 INJ PSO LQF 1X100KU + S

B03XA01 58685 NEORECORMON

MULTIDOSE 50000 INJ PSO LQF 1X50KU + SAT

B03XA01 58688 NEORECORMON for

RECO-PEN INJ 10000 PSO LQF 3X10KU + S

B03XA01 58744 NEORECORMON for

RECO-PEN INJ 20000 PSO LQF 3X20KU + SAT

--------------------------------------------------------------------------



Annex 7



List of in-patient medical facilities-center for the treatment of burns

+--+----------+--------------------------+-----------------+-------------------+

| # | CORPORATE ID | The name of the registered equipment | Head Office | The workplace |

+--+----------+--------------------------+-----------------+-------------------+

|1. | 00064173 | University Hospital | Prague 10 | The clinic |

| | | Královské Vinohrady | | Burns |

| | | | | medicine |

+--+----------+--------------------------+-----------------+-------------------+

|2. | 00843989 | University Hospital | Ostrava-Poruba | Burns |

| | | first | | Center |

+--+----------+--------------------------+-----------------+-------------------+

|3. | 65,269,705 | Faculty hospital Brno | Brno | Center (clinic) |

| | | | | Burns |

| | | | ' | ' and reconstruction |

| | | | | surgery |

+--+----------+--------------------------+-----------------+-------------------+



Annex 8



List of in-patient medical facilities-center for treatment of cystic

Fibrosis

+--+---------+---------------------------+---------------+---------------------+

| # | CORPORATE ID | The name of the registered equipment | Head Office | The workplace |

+--+---------+---------------------------+---------------+---------------------+

|1. | 00064203 | Teaching hospital in motol | Prague 5 | 2. The children's clinic |

| | | | | THORN |

+--+---------+---------------------------+---------------+---------------------+

|2. | 65,269,705 | Faculty hospital Brno | Brno | Infectious diseases clinic of the DFN, |

| | | | | FN | clinic pleuropneumonia

+--+---------+---------------------------+---------------+---------------------+

|3. | 00179906 | University Hospital | Hradec Králové | The children's clinic |

| | | Hradec Králové | | |

+--+---------+---------------------------+---------------+---------------------+

|4. | 00669806 | Faculty hospital Pilsen | Pilsen | The children's clinic |

+--+---------+---------------------------+---------------+---------------------+

| 5. | 00098892 | Faculty hospital Olomouc | Olomouc | The children's clinic |

| | | | and THORN clinic | |

+--+---------+---------------------------+---------------+---------------------+



Annex 9



The list of medicinal products for the treatment of cystic fibrosis

---------------------------------------------------------------------

ATC Code the name of the add-in name

---------------------------------------------------------------------

J01CR05 TAZOCIN 2.25 GM 84783 INJ SIC 1 x 2.25 GM

J01CR05 TAZOCIN 4.5 GM 84784 INJ SIC 1 x 4.5 GM



J01DA 94756 2GM SULPERAZON IM/IV INJ SIC 1 x (1GM + 1GM)



J01DA11 76353 1 g 1X1GM FORTUM INJ SIC

J01DA11 76354 FORTUM 2 g INJ SIC 1X2GM

J01DA11 76355 FORTUM INJ 500 mg SIC 1X500MG



87199 J01DA24 MAXIPIME 1 GM INJ SIC 1X1GM

87200 J01DA24 MAXIPIME 2 GM INJ SIC 1X2GM

87198 J01DA24 MAXIPIME INJ 500 mg SIC 1X500MG



J01DH02 83417 MERONEM INJ SIC 10X1GM



J01GB06 11785 AMIKIN INJ 1 G 1X4ML/1GM

J01GB06 03951 AMIKIN 100 mg 1X2ML/INJ 100 mg

J01GB06 03952 1X2ML/AMIKIN INJ 500 mg 500 mg



J01GB07 NETROMYCINE 200 mg/2 ml 90485 INJ 1X2ML/200 mg

J01GB07 NETROMYCINE 400 mg/2 ml 83736 INJ 1X2ML/400 mg



J01MA02 53715 CIFLOXINAL TBL OBD 200X250MG

J01MA02 CIPHIN for 53922

200 mg/100 ml INFUSION BROTH POWDER. INF 1X100ML/200 mg

53921 J01MA02 CIPHIN for

INFUSIONE 100 mg/50 ml INF 1X50ML/100 mg

J01MA02 56830 CIPLOX INF 1X100ML (plastic)

44989 J01MA02 CIPLOX 250 TBL OBD 50X250MG

J01MA02 44986 CIPLOX 500 TBL OBD 50X500MG

J01MA02 96040 CIPRINOL 100 mg/10 ml INF 5X10ML/100 mg

J01MA02 100 mg/50 ml 59829 CIPRINOL INF 1X50ML/100 mg

J01MA02 59830 CIPRINOL 200 mg/100 ml 1X100ML INF/200 mg



J01XB01 COLIMYCINE SIC 50X1MU 61178 INJ



J02AA01 44141 ABELCET INF 10X10ML/50 mg

44148 10X10ML J02AA01 ABELCET INF/50 mg

44142 10X20ML J02AA01 ABELCET INF/100 mg

J02AA01 44149 ABELCET INF 10X20ML/100 mg



J02AC01 DIFLAZON 1X100ML/INF 58431 200 mg

J02AC01 DIFLAZON 28X100MG 59787 100 CPS

64946 DIFLUCAN J02AC01 I.V. INF 1X100ML 2 mg/ML

J02AC01 46979 FLUCONAZOL-SLOVAKOFARMA

For INF INF 1X100ML/200 mg

66036 J02AC01 MYCOMAX 100 CPS 28X100MG

65989 INF INF J02AC01 MYCOMAX 1X100ML/200 mg

J02AC01 59872 MYCOSYST INF 10X100ML 2 mg/ML

59874 MYCOSYST CPS 100 mg J02AC01 28X100MG
J02AC02 58872 SPORANOX POR CPS DUR28X100MG



R05CB13 77521 PULMOZYME INH THESS 6 x 2.5 ML



A09AA02 44015 KREON 10000 CPS 20

A09AA02 68989 KREON 25000 50 CPS



V06DB 59109 FRESUBIN 750 MCT SOL 12X500ML

V06DB POR SUS 56244 INKODIET STANDARD 12X500ML

V06DB INKOPEPTID POR SUS 56246 SONDE 12X500ML

45529 V06DB NUTRISON ENERGY SOL 1X1000ML (BAG)

NUTRISON MULTI FIBRE 45793 V06DB SOL 1X1000ML (BAG)

V06DB 61454 NUTRISON POWDER PLV 1X430GM

V06DB 53375 NUTRISON STANDARD SOL 1X1000ML (BAG)

V06DB 49470 SUPPORTAN NEUTRAL SOL 12X500ML

V06DB SURVIMED OPD 57357 NEUTRAL SOL 12X500ML

V06DC 1X400GM FANTOMALT PLV 75153

---------------------------------------------------------------------



Annex 10



List of inpatient health care facility-workplaces for the treatment

oncologically ill children

+--+----------+---------------------------+---------+---------------+

| # | CORPORATE ID | The name of the registered equipment | Head Office | The workplace |

+--+----------+---------------------------+---------+---------------+

|1. | 00064203 | Teaching hospital in motol | Prague 5 | The children's clinic |

+--+----------+---------------------------+---------+---------------+

|2. | 65,269,705 | Faculty hospital Brno | Brno | The children's Department |

| | | | | Oncology |

+--+----------+---------------------------+---------+---------------+



Annex 11



The list of medicinal products for the treatment of oncologically ill children

----------------------------------------------------------------------

ATC Code the name of the add-in name

----------------------------------------------------------------------

B03XA01 85530 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.2 ML/3KU

B03XA01 85531 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/4KU

B03XA01 57340 EPREX 1000 IU/0.1 ML 6 x 0.5 ML INJ SOL/5KU

B03XA01 57341 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/6KU

B03XA01 57342 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/7KU

B03XA01 57343 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.5 ML/8KU

B03XA01 57344 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/9KU

B03XA01 85532 EPREX 1000 IU/0.1 ML INJ SOL 6X1ML/10KU

B03XA01 85528 EPREX 200 IU/0.1 ML 6 x 0.5 ML INJ SOL/1KU

B03XA01 93579 EPREX 200 IU/0.1 ML INJ SOL 6X1ML/2KU

B03XA01 02267 EPREX 40, 000 INJ SOL 1X1ML/40KU

B03XA01 85529 EPREX 400 IU/0.1 ML 6 x 0.5 ML INJ SOL/2KU

B03XA01 58451 NEORECORMON 10 000 IU INJ SOL 6 x 0.6 ML/10KU

B03XA01 64816 NEORECORMON 1000 IU INJ SOL 6 x 0.2 ML/1KU

B03XA01 58453 NEORECORMON 20 000 IU INJ SOL 6 x 0.6 ML/20KU

B03XA01 64812 NEORECORMON 2000 IU INJ SOL 6 x 0.2 ML/2KU

B03XA01 64818 NEORECORMON 3000 IU INJ SOL 6 x 0.2 ML/3KU

B03XA01 06221 NEORECORMON 4000IU INJ SOL 6 x 0.2 ML/4KU

B03XA01 64814 NEORECORMON 500 IU INJ SOL 6 x 0.2 ML/500UT

B03XA01 58449 NEORECORMON 5000 IU INJ SOL 6 x 0.2 ML/5KU

B03XA01 58686 NEORECORMON MULTIDOSE 100,000 INJ PSO LQF 1X100KU + S

B03XA01 58685 NEORECORMON MULTIDOSE 50000 INJ PSO LQF 1X50KU + SAT

B03XA01 58688 NEORECORMON for RECO-PEN INJ 10000 PSO LQF 3X10KU + S

B03XA01 58744 NEORECORMON for RECO-PEN INJ 20000 PSO LQF 3X20KU + SAT

----------------------------------------------------------------------

J02AA01 44141 ABELCET INF 10X10ML/50 mg

44148 10X10ML J02AA01 ABELCET INF/50 mg

44142 10X20ML J02AA01 ABELCET INF/100 mg

J02AA01 44149 ABELCET INF 10X20ML/100 mg

32144 AMPHOCIL J02AA01 100 mg INF PLV SOL 10X100MG

32142 AMPHOCIL J02AA01 50 mg INF PLV SOL 10X50MG

J02AA01 AMPHOTERICIN B INJ 57548 SQUIBB SIC 1X50MG

----------------------------------------------------------------------



Annex 12



List of inpatient health care facility-kardiocenter, implementing the

the performances of invasive and interventional cardiology, according to section 2 paragraph 7, subparagraphs (l))

and m)

+---+----------+------------------------------------+-------------------+

| No. | CORPORATE ID | The name of the registered equipment | Head Office |

+---+----------+------------------------------------+-------------------+

| 1. | 00064165 | General University Hospital | Prague 2 |

+---+----------+------------------------------------+-------------------+

| 2. | 00023001 | Institute of clinical and experimental | Prague 4 |

| | | medicine | |

+---+----------+------------------------------------+-------------------+

| 3. | 00064203 | Teaching hospital in motol | Prague 5 |

+---+----------+------------------------------------+-------------------+

| 4. | 00023884 | Homolce Hospital | Prague 5 |

+---+----------+------------------------------------+-------------------+

| 5. | 61,383,082 | Central military hospital | Prague 6 |

+---+----------+------------------------------------+-------------------+

| 6. | 49,679,236 | Cardiology na has | Prague 8 |

+---+----------+------------------------------------+-------------------+

| 7. | 00064173 | University Hospital | Prague 10 |

| | | Královské Vinohrady | |

+---+----------+------------------------------------+-------------------+

| 8. | 00072711 | Hospital České Budějovice | České Budějovice |

+---+----------+------------------------------------+-------------------+

| 9. | 00669806 | Faculty hospital Pilsen | Pilsen |

+---+----------+------------------------------------+-------------------+

| 10 | 00179906 | University Hospital Hradec Králové | Hradec Králové |

+---+----------+------------------------------------+-------------------+

| 11. | 65,269,705 | Faculty hospital Brno | Brno |

+---+----------+------------------------------------+-------------------+

12. | 00159816 | The University Hospital. Anna | Brno |

+---+----------+------------------------------------+-------------------+

| 13. | 00209775 | The cardiovascular Center | Brno |

| | |, and transplant surgery | |

+---+----------+------------------------------------+-------------------+

| 14 | 00843989 | University Hospital Ostrava | Ostrava-Poruba |

| | | Ostrava-Poruba | |

+---+----------+------------------------------------+-------------------+

| 15 | 00635162 | Municipal Hospital Ostrava-Fifejdy | Moravská Ostrava |

+---+----------+------------------------------------+-------------------+

| 16 | 48,401,129 | The hospital has: | Třinec |

+---+----------+------------------------------------+-------------------+

| 17 | 00098892 | Faculty hospital Olomouc | Olomouc |

+---+----------+------------------------------------+-------------------+

| 18. | 00089915 | Bata hospital | Zlín |

+---+----------+------------------------------------+-------------------+

| 19 | 00829951 | Hospital Liberec | Liberec |

+---+----------+------------------------------------+-------------------+



Annex 13



List of inpatient health facilities implementing Endovascular

tepenných treatment of aneurysms and dissection, stenosis of cerebral arteriovenous

short circuits and malformations

+---+---------+------------------------------------+------------------+

|č. | CORPORATE ID | The name of the registered equipment | Head Office |

+---+---------+------------------------------------+------------------+

' |1 '. | 00064165 | General University Hospital | Prague 2 |

+---+---------+------------------------------------+------------------+

|2. | 00023001 | Institute of clinical and experimental | Prague 4 |

| | | medicine | |

+---+---------+------------------------------------+------------------+

| 3. | 00023884 | Homolce Hospital | Prague 5 |

+---+---------+------------------------------------+------------------+

| 4. | 61,383,082 | Central military hospital | Prague 6 |

+---+---------+------------------------------------+------------------+

| 5. | 00064173 | University Hospital | Prague 10 |

| | | Královské Vinohrady | |

+---+---------+------------------------------------+------------------+

| 6. | 00669806 | Faculty hospital Pilsen | Pilsen |

+---+---------+------------------------------------+------------------+

| 7. | 00179906 | University Hospital Hradec Králové | Hradec Králové |

+---+---------+------------------------------------+------------------+

| 8. | 65,269,705 | Faculty hospital Brno | Brno |

+---+---------+------------------------------------+------------------+

| 9. | 00843989 | University Hospital Ostrava | Ostrava-Poruba |

| | | Ostrava-Poruba | |

+---+---------+------------------------------------+------------------+

| 10 | 00098892 | Faculty hospital Olomouc | Olomouc |

+---+---------+------------------------------------+------------------+

| 11. | 00159816 | The University Hospital. Anna | Brno |

+---+---------+------------------------------------+------------------+

12. | 00064211 | Faculty hospital Bulovka | Prague 8 |

+---+---------+------------------------------------+------------------+

| 13. | 00064203 | Teaching hospital in motol | Prague 5 |

+---+---------+------------------------------------+------------------+

| 14 | 00072711 | Hospital České Budějovice | České Budějovice |

+---+---------+------------------------------------+------------------+

| 15 | 00673544 | Masaryk hospital with policlinic | Ústí nad Labem |

+---+---------+------------------------------------+------------------+

| 16 | 00829951 | Hospital Liberec | Liberec |

+---+---------+------------------------------------+------------------+



Annex 14



List of in-patient medical facilities-workplaces for operating treatment

stress incontinence
+----+---------+-----------------------------------+--------------------+

| No. | CORPORATE ID | The name of the registered equipment | Head Office |

+----+---------+-----------------------------------+--------------------+

| 1. | 00064211 | Faculty hospital Bulovka | Prague 8 |

+----+---------+-----------------------------------+--------------------+

| 2. | 00023698 | The Institute for the care of mother and child | Prague 4 |

+----+---------+-----------------------------------+--------------------+

| 3. | 00064165 | General University Hospital | Prague 2 |

+----+---------+-----------------------------------+--------------------+

| 4. | 00843989 | University Hospital Ostrava | Ostrava-Poruba |

| | | Ostrava-Poruba | |

+----+---------+-----------------------------------+--------------------+

| 5. | 00844896 | Hospital with policlinic | Havířov-Město |

+----+---------+-----------------------------------+--------------------+

| 6. | 48,512,478 | The Hospital of Merciful brethren | Brno |

+----+---------+-----------------------------------+--------------------+

| 7. | 65,269,705 | Faculty hospital Brno | Brno |

+----+---------+-----------------------------------+--------------------+

| 8. | 60,726,636 | Hospital Atlas, a.s. | Zlín |

+----+---------+-----------------------------------+--------------------+

| 9. | 00089915 | Bata hospital | Zlín |

+----+---------+-----------------------------------+--------------------+

| 10. | 00875384 | Kladno Hospital | Kladno |

+----+---------+-----------------------------------+--------------------+

| 11. | 49,813,692 | The first surgical private | Hradec Králové |

| | SANUS | Center | |

+----+---------+-----------------------------------+--------------------+

12. | 00072711 | Hospital České Budějovice | České Budějovice |

+----+---------+-----------------------------------+--------------------+

| 13. | 00829838 | Hospital | Jablonec nad Nisou |

+----+---------+-----------------------------------+--------------------+

| 14. | 00669806 | Faculty hospital Pilsen | Pilsen |

+----+---------+-----------------------------------+--------------------+

| 15. | 00098892 | Faculty hospital Olomouc | Olomouc |

+----+---------+-----------------------------------+--------------------+

| 16. | 00390780 | Hospital Břeclav | Břeclav |

+----+---------+-----------------------------------+--------------------+

| 17. | 00874621 | Hospital with policlinic Melnik | Melnik |

+----+---------+-----------------------------------+--------------------+

| 18. | 00190489 | Hospital Pardubice | Pardubice |

+----+---------+-----------------------------------+--------------------+

| 19. | 00673544 | Masaryk hospital with policlinic | Ústí nad Labem |

+----+---------+-----------------------------------+--------------------+

| 20. | 00064203 | Teaching hospital in motol | Prague 5 |

+----+---------+-----------------------------------+--------------------+



Annex 15



A list of the medicinal products containing the active substance erythropoietin for the treatment of

germinal tumors, ovarian cancer, lung cancer, cancer

breast, cancer of the cervix, squamous cell carcinomas in the orofacial area, malignant

tumors of the placenta, multiple myeloma and chronic lymphocytic leukemia

----------------------------------------------------------------

ATC Code the name of the add-in name

----------------------------------------------------------------

B03XA01 85530 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.2 ML/3KU

B03XA01 85531 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/4KU

B03XA01 57340 EPREX 1000 IU/0.1 ML 6 x 0.5 ML INJ SOL/5KU

B03XA01 57341 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/6KU

B03XA01 57342 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.4 ML/7KU

B03XA01 57343 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.5 ML/8KU

B03XA01 57344 EPREX 1000 IU/0.1 ML INJ SOL 6 x 0.6 ML/9KU

B03XA01 85532 EPREX 1000 IU/0.1 ML INJ SOL 6X1ML/10KU

B03XA01 85528 EPREX 200 IU/0.1 ML 6 x 0.5 ML INJ SOL/1KU

B03XA01 93579 EPREX 200 IU/0.1 ML INJ SOL 6X1ML/2KU

B03XA01 02267 EPREX 40, 000 INJ SOL 1X1ML/40KU

B03XA01 85529 EPREX 400 IU/0.1 ML 6 x 0.5 ML INJ SOL/2KU

B03XA01 58451 NEORECORMON 10 000 IU INJ SOL 6 x 0.6 ML/10KU

B03XA01 64816 NEORECORMON 1000 IU INJ SOL 6 x 0.2 ML/1KU

B03XA01 58453 NEORECORMON 20 000 IU INJ SOL 6 x 0.6 ML/20KU

B03XA01 64812 NEORECORMON 2000 IU INJ SOL 6 x 0.2 ML/2KU

B03XA01 64818 NEORECORMON 3000 IU INJ SOL 6 x 0.2 ML/3KU

B03XA01 06221 NEORECORMON 4000IU INJ SOL 6 x 0.2 ML/4KU

B03XA01 64814 NEORECORMON 500 IU INJ SOL 6 x 0.2 ML/500UT

B03XA01 58449 NEORECORMON 5000 IU INJ SOL 6 x 0.2 ML/5KU

B03XA01 58686 NEORECORMON

MULTIDOSE 100,000 INJ PSO LQF 1X100KU + S

B03XA01 58685 NEORECORMON

MULTIDOSE 50000 INJ PSO LQF 1X50KU + SAT

B03XA01 58688 NEORECORMON

For the RECO-PEN INJ 10000 PSO LQF 3X10KU + S

B03XA01 58744 NEORECORMON for

RECO-PEN INJ 20000 PSO LQF 3X20KU + SAT

----------------------------------------------------------------



Annex 16



The list of selected inpatient facility-center for treatment of multiple

Myeloma and chronic lymphocytic leukemia

+--+----------+-----------------------------+--------+--------------------------+

| # | CORPORATE ID | The name of the registered equipment | Head Office | The workplace |

+--+----------+-----------------------------+--------+--------------------------+

|1. | 00064165 | General University Hospital | Prague 2 | Internal medicine |

+--+----------+-----------------------------+--------+--------------------------+

|2. | 00023736 | Institute of Hematology and blood | Prague 2 | Hematology |

| | | transfusion | ||

+--+----------+-----------------------------+--------+--------------------------+

|3. | 00064173 | Royal University Hospital | Prague 10 | Hematology Department |

| | | Vinohrady | ||

+--+----------+-----------------------------+--------+--------------------------+

|4. | 00179906 | University Hospital | Hradec | Hematology Department |

| | | Hradec Králové | Kings |

+--+----------+-----------------------------+--------+--------------------------+

| 5. | 00669806 | Faculty hospital Pilsen | Pilsen | Hematology Department |

+--+----------+-----------------------------+--------+--------------------------+

| 6 | 00098892 | Faculty hospital Olomouc | Olomouc | Hematoonkologická clinic |

+--+----------+-----------------------------+--------+--------------------------+

| 7 | 65,269,705 | Faculty hospital Brno | Brno | Internal hematoonkologická |

| | | | | Clinic |

+--+----------+-----------------------------+--------+--------------------------+

| 8 | 00064203 | Faculty hospital Motol | Prague | Oncology |

+--+----------+-----------------------------+--------+--------------------------+



Annex 17



The list of selected inpatient facility-center for treatment of germ

tumors, ovarian cancer, lung cancer, breast cancer,

Carcinoma of the cervix, squamous cell carcinomas in the orofacial area, malignant tumors

the placenta

+----+---------+-----------------------------+----------+-------------------------------+

| No. | CORPORATE ID | The name of the registered equipment | Head Office | The workplace |

+----+---------+-----------------------------+----------+-------------------------------+

| 1. | 00064165 | General University Hospital | Prague 2 | Internal medicine |

+----+---------+-----------------------------+----------+-------------------------------+

| 2. | 00064190 | The University Thomayer's | Prague 4 | Oncology |

| | Hospital Prague | | | |

+----+---------+-----------------------------+----------+-------------------------------+

| 3. | 00064173 | University Hospital | Prague 10 | Oncology |

| | | Královské Vinohrady | | |

+----+---------+-----------------------------+----------+-------------------------------+

| 4. | 00179906 | University Hospital | Hradec | Oncology |

| | | Hradec Králové | Kings | |

+----+---------+-----------------------------+----------+-------------------------------+

| 5. | 00669806 | Faculty hospital Pilsen | Pilsen | Oncology |

+----+---------+-----------------------------+----------+-------------------------------+

| 6. | 00098892 | Faculty hospital Olomouc | Olomouc | Oncology |

+----+---------+-----------------------------+----------+-------------------------------+

| 7. | 00072711 | Hospital České Budějovice | Czech | Oncology |

| | | | České Budějovice | |

+----+---------+-----------------------------+----------+-------------------------------+

| 8. | 00843989 | University Hospital | Ostrava-| Oncology |

| | | first | Poruba | |

+----+---------+-----------------------------+----------+-------------------------------+

| 9. | 00159816 | University Hospital | Brno | Department of clinical |

| | |. Anna | |, and radiation oncology |

+----+---------+-----------------------------+----------+-------------------------------+

| 10. | 65,269,705 | Faculty hospital Brno | Brno | Oncology |

+----+---------+-----------------------------+----------+-------------------------------+

| 11. | 00209805 | Masaryk Memorial Cancer Institute | Brno | Oncology |

+----+---------+-----------------------------+----------+-------------------------------+

12. | 00064203 | Faculty hospital Motol | Prague 5 | Oncology adult |

+----+---------+-----------------------------+----------+-------------------------------+
| 13. | 00064211 | Faculty hospital Bulovka | Prague 8 | Department of radiation oncology |

+----+---------+-----------------------------+----------+-------------------------------+



Annex 18



Glykoproteinových blockers receptor IIb/IIIa

----------------------------------------------------------

ATC Code the name of the add-in name

----------------------------------------------------------

B01AC13 56610 REOPRO 1X5ML/INJ 10 mg

B01AC16 46802 INTEGRILIN 0.75 MG/ML 1X100ML/INF 75MG

B01AC16 46800 INTEGRILIN, 2 mg/ML 1X10ML/INJ 20 mg

----------------------------------------------------------



Annex 19



Selected list of contracted medical facilities, in which the

treatment is provided in the form of intravenously administered agamaglobulinémií

immunoglobulin preparations

+----+---------+----------------------------------+----------+-------------------------+

| No. | CORPORATE ID | The name of the medical equipment | Head Office | The workplace |

+----+---------+----------------------------------+----------+-------------------------+

| 1. | 00064203 | Faculty hospital Motol | Prague 5 | Department of Immunology |

+----+---------+----------------------------------+----------+-------------------------+

| 2. | 00064165 | General University Hospital | Prague 2 | The University Health Centre |

| | | | ' |1 ' of medicine and GENERAL TEACHING HOSPITAL, Institute |

| | | | Immunology and | |

| | | | |-Microbiology |

+----+---------+----------------------------------+----------+-------------------------+

| 3. | 00023728 | Revmatologický Institute | Prague | |

+----+---------+----------------------------------+----------+-------------------------+

| 4. | 00159816 | The University Hospital. Anna | Brno | Institute of clinical |

| | | | | Immunology and Allergology |

+----+---------+----------------------------------+----------+-------------------------+

| 5. | 00179906 | University Hospital Hradec Králové | Hradec | Institute of Clinical Immunology |

| | | | Kings | and Allergology |

+----+---------+----------------------------------+----------+-------------------------+

| 6. | 673,536 | The regional hygiene station | The mouth of the n. | Immunological Department |

| | | | Labem | |

+----+---------+----------------------------------+----------+-------------------------+

| 7. | 00098892 | Faculty hospital Olomouc | Olomouc | Department of Allergology |

| | | | ' | ' and Clinical Immunology |

+----+---------+----------------------------------+----------+-------------------------+

| 8. | 00669806 | Faculty hospital Pilsen | Pilsen | Department of Immunology |

| | | | |, and Allergology |

+----+---------+----------------------------------+----------+-------------------------+

| 9. | 64,628,299 | The regional hygiene station | Ostrava | Immunological Department |

+----+---------+----------------------------------+----------+-------------------------+

| 10. | 00072711 | Hospital České Budějovice | Czech | Internal Department |

| | | | Budějovice |-Gastroenterology |

+----+---------+----------------------------------+----------+-------------------------+



Annex 20



The amount and conditions of payment under section 6 (1). 3



The amount and conditions of payment for individual types of care are set out

as follows:



1. the health care provided by the medical rescue service



and the payment of flat-rate) reference period is 1. half of 2002.

Interim payment will be equal to 112% of the 1/6 remuneration for granted and

recognized health care during the reference period, with the understanding that if

medical device reports less than 90% of the unique treated

in the reference period, it will be a flat rate

recalculated as the product of interim payments and the index i, where i = (number of

unique treated policyholders 1. half of 2003)/(number of

unique treated policyholders 1. half of 2002)



(b) the remuneration referred to in the list). The minimum point value is $ 0.99.

Any increase in the value of the item must not exceed the maximum price point

the renowned výměrem MF no 01/2002, respectively No. 01/2003.



2. the medical care provided in the context of the transport of the wounded, sick and

expectant mothers



and the payment of flat-rate) reference period is 1. half of 2002.

Interim payment will be equal to 112% of the 1/6 remuneration for granted and

recognized health care during the reference period, with the understanding that if

medical device reports less than 90% of the unique treated

in the reference period, it will be a flat rate

recalculated as the product of interim payments and the index i, where



I = (number of unique treated policyholders for 1 half-year 2003)/

(number of unique treated policyholders for 1 half-year 2002)



(b) the remuneration referred to in the list). The minimum point value is Czk 0.87.

Any increase in the value of the item must not exceed the maximum price point

the renowned výměrem MF no 01/2002, respectively No. 01/2003.



3. the health care provided by the medical services of first aid



and the payment of flat-rate) reference period is 1. half of 2002.

Interim payment will be equal to 112% of the 1/6 remuneration for granted and

recognized health care during the reference period, with the understanding that if

medical device reports less than 90% of the unique treated

in the reference period, it will be a flat rate

recalculated as the product of interim payments and the index i, where



I = (number of unique treated policyholders for 1 half-year 2003)/

(number of unique treated policyholders for 1 half-year 2002)



(b) the remuneration referred to in the list). The minimum point value is Czk 0.87.

Any increase in the value of the item must not exceed the maximum price point

the renowned výměrem MF no 01/2002, respectively No. 01/2003.



Annex 21



The procedure to calculate the increase of the remuneration under section 8 (2). 1



NUZZ = (P01/-P02 1) x to x UZZ01



where:



NUZZ = increase in remuneration for a specific medical device 1.

half-year 2003



P01 = actual revenue from a selection of premiums for individual health

insurance companies total after the reallocation of under 1. half of 2002 (that is from 1 to 6.

redistribution including)



P02 = actual revenue from a selection of premiums for individual health

insurance companies total after the reallocation of under 1. half of 2003 (that is from 1 to 6.

redistribution including)



K = 0.7



UZZ01 = reimbursement for a particular medical device 1. half-year 2003

declared and recognized by the medical establishment and health

the insurance company to 30. November 2003, minus the payments for the items in the

§ 2 (2). 7 paid in the relevant period.



The conditions for the calculation and payment:



1. If the P02/P01 = 1, then < increase does not.



2. In the event that in the 1. half of 2003 there has been an increase in the contract

the capacity of medical device compared to 1. half of 2002, the volume of this

care is not included in the calculation in the UZZ01 item according to § 8, Appendix 21.



3. In order to ensure the balance of the balance of health insurance companies may

The Ministry of health, the health of the individual factor

the insurance company change. During the presentation of the results of the management of health

the insurance company for 1. half of 2003, individual health insurance

ask the Health Department about a change in the coefficient in order to

maintain balance balance of insurance companies.



1) Decree No. 134/1998 Coll. issuing the list of health interventions

with point values, as amended by decrees no. 55/2000 SB., no. 135/2000

Coll., no 449/2000 Coll., no 101/2002 Coll. and no 291/2002 Sb.



2) article II of Act No. 459/2000 Coll., amending Act No. 48/1997 Coll., on

public health insurance and amending and supplementing certain

related laws, as amended. Annex 1, point (B))

1. Government Regulation No. 458/2000 Coll., laying down the values of point and

the amount of the reimbursement of health care paid for by public health insurance for

1. half of the year 2001.



3) article II of Act No. 459/2000 Coll., section 2 (2). 7 (b). (e)) Government Regulation No.

487/2000 Sb.



4) article II of Act No. 459/2000 Coll., section 2 (2). 7 (b). I) Government Regulation No.

487/2000 Sb.



5) article II of Act No. 459/2000 Sb. Annex 2, point (B)) 1. Regulation of the Government

No 487/2000 Sb.



6) article II of Act No. 459/2000 Coll., section 4, paragraph 4. 2 regulation of the Government No. 487/2000

SB.



7) article II of Act No. 459/2000 Coll., section 5 (3). 2 regulation of the Government No. 487/2000

SB.



§ 40 paragraph 8). 2 of Act No. 48/1997 Coll.



9) article II of Act No. 459/2000 Coll., section 6 (a). (b)) Government Regulation No. 487/2000

SB.

Related Laws